Pharmaceutical

How Cell-Free mRNA Templates Support Faster Research with High-Quality and Quick Turnaround, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how integrated solutions — from vector design to cell-free in vitro transcription (IVT) template preparation —…

5 months ago

AI in Clinical Trials: Early Use Cases and Innovations, Upcoming Webinar Hosted by Xtalks

TORONTO, July 30, 2025 /PRNewswire/ -- In this free webinar, discover practical use cases of AI in clinical trials —…

5 months ago

Flow Sciences Announces New Office in North Carolina’s Research Triangle Park

LELAND, N.C., July 30, 2025 /PRNewswire/ -- Flow Sciences, a global leader in advanced containment solutions, today announced the opening…

5 months ago

Emerald Clinical Trials Confirms CEO Transition and Continuity Plan

SINGAPORE, July 30, 2025 /PRNewswire/ -- Emerald Clinical Trials, a leading global clinical research organization, today announced a leadership transition.…

5 months ago

Labcorp Introduces Test Finder, a First-of-Its-Kind Generative AI Tool to Simplify Lab Test Search

Test Finder interprets provider questions in context to deliver curated, clinically relevant results, going beyond traditional search Developed in collaboration…

5 months ago

Survey Finds Medtechs Lack Confidence in Regulatory Data Quality

Veeva MedTech report reveals opportunity to move beyond manual processes for speed and compliance PLEASANTON, Calif., July 30, 2025 /PRNewswire/…

5 months ago

Vivos Therapeutics Adds to Management Team to Support Expansion and Growth

Two Key Hires Add Significant Experience and Strengthen Vivos’ Ability to Scale Its Promising New Sleep Testing Center and Direct…

5 months ago

Moleculin Receives Notice of Intent to Grant New European Patent for Annamycin

– New patent enhances market position in Europe HOUSTON, July 30, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX)…

5 months ago

Ultragenyx to Host Conference Call for Second Quarter 2025 Financial Results and Corporate Update

NOVATO, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development…

5 months ago

Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates

NEW YORK and SANTA BARBARA, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (Nasdaq: PTIX) (the “Company”) today…

5 months ago